Literature DB >> 26223741

Salvage surgery for recurrent oropharyngeal cancer: post-operative oncologic and functional outcomes.

Dorian Culié1, Karen Benezery2, Emmanuel Chamorey3, Marc Ettaiche3, Jonathan Fernandez1, Gilles Poissonnet1, Jean-Christophe Riss1, Jean-Michel Hannoun-Lévi2, Marie-Eve Chand2, Axel Leysalle2, Esma Saada4, Anne Sudaka5, Juliette Haudebourg5, François Demard1, José Santini1, Frédéric Peyrade4, Olivier Dassonville1, Alexandre Bozec1.   

Abstract

CONCLUSION: Post-operative outcomes of salvage surgery for recurrent oropharyngeal squamous-cell carcinoma (OPSCC) were acceptable. Pathologic overall, T- or N-stage and patient comorbidities were the main predictors of patient clinical outcomes.
OBJECTIVES: To evaluate post-operative outcomes of salvage surgery in patients with recurrent OPSCC and to determine their predictive factors.
MATERIALS AND METHODS: This study retrospectively reviewed the electronic medical records of all patients who underwent salvage surgery for recurrent OPSCC, between 2000-2013, in our institution. Overall survival (OS) and cause-specific survival (SS) were determined by Kaplan-Meier analysis. Predictive factors of post-operative outcomes were investigated by using univariate and multivariate analyses.
RESULTS: A total of 34 patients were included in this study. Local and general post-operative complication rates were 26% and 27%, respectively. A high level of comorbidity (Kaplan Feinstein Index: KFI ≥ 2) was the only factor associated with a higher risk of local (p = 0.03) and general (p = 0.04) complications. OS and SS rates at 3 years were 48% and 61%, respectively. In multivariate analysis, pathologic overall stage ≥ III was a significant predictor of OS (p = 0.02) and pathologic T-stage ≥ 3 was a significant predictor of SS (p = 0.01). Mean pre-operative and post-operative DOSS (dysphagia outcome and severity scale) scores were 4.4 and 3.9, respectively.

Entities:  

Keywords:  head and neck cancer; oropharynx; radiotherapy; recurrence; salvage surgery; squamous cell carcinoma

Mesh:

Year:  2015        PMID: 26223741     DOI: 10.3109/00016489.2015.1066935

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.

Authors:  Molly E Heft Neal; Julia Brennan; Catherine T Haring; J Chad Brenner; Francis Worden; Paul Swiecicki; Michelle Mierzwa; Keith A Casper; Kelly M Malloy; Chaz L Stucken; Scott A McLean; Mark E Prince; Carol R Bradford; Gregory T Wolf; Andrew G Shuman; Steven B Chinn; Douglas B Chepeha; Andrew J Rosko; Matthew E Spector
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-19       Impact factor: 2.503

2.  A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response.

Authors:  Zeno A R Gouw; Bas Jasperse; Jan-Jakob Sonke; Wilma D Heemsbergen; Arash Navran; Olga Hamming-Vrieze; Jan Paul de Boer; Michiel W M van den Brekel; Abrahim Al-Mamgani
Journal:  Clin Transl Radiat Oncol       Date:  2017-08-04

3.  Diagnosis and treatment of oropharyngeal dysphagia after total laryngectomy with or without pharyngoesophageal reconstruction: Systematic review.

Authors:  Lisanne T Terlingen; Walmari Pilz; Myrthe Kuijer; Bernd Kremer; Laura W Baijens
Journal:  Head Neck       Date:  2018-11-26       Impact factor: 3.147

4.  Impact of geniohyoid and masseter muscle masses on dysphagia after salvage surgery and radiotherapy in head and neck cancer.

Authors:  Nao Hashida; Hiroshi Shamoto; Keisuke Maeda; Hidetaka Wakabayashi
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.